US Court of Appeals Affirms Summary Judgment Decision in Seroquel Patent Litigation Posted on:28 Sep 09 AstraZeneca today announced that the US Court of Appeals for the Federal Circuit has...
the Seroquel litigation, and served as lead counsel in the Risperdal Stange v Janssen and Johnson & Johnson product liability trial. Kelly obtained summary judgment in the first Seroquel...
The $647 million reserve for Seroquel litigation includes money “to account for the current and anticipated future settlement costs regarding the Seroquel product liability claims, past...
AstraZeneca granted summary judgment in ... ; Judge grants RIM a stay in Visto patent ... ; Pressure Products Prevails in Patent Inf... ; Barracuda bites back at Trend Micro in C...
AstraZeneca granted summary judgment in Seroquel patent litigation Published: 03 Jul 2008 AstraZeneca granted summary judgment in Seroquel patent litigation AstraZeneca has announced that...
AstraZeneca has prevailed: The first jury to hear a Seroquel case decided that the warnings on its label were adequate, so patients and doctors should have had enough information about the drug's risks. "The jury determined... that the information in the Seroquel label provided prescribing doctors an adequate warning with respect to diabetes," AstraZeneca's lawyer told Bloomberg after the verdict. Lawyers for the plaintiff, Vietnam veteran Ted Baker, had alleged that AZ had downplayed Seroquel's risks, failing to adequately warn doctors and pat ...
Elixir signs license agreement with Bost... ; MIT sues Affymetrix for patent infringem... ; Barracuda sues Trend Micro as patent spa... ; AstraZeneca granted summary judgment in ...
GEO2 Licenses Patent Portfolio to Cornin... ; US Court of Appeals Affirms Summary Judg... ; Patent litigation suit both victorious a... ; 인포메이션디스플레이(조명용 백색 oled)
Related Professionals ; Mark J. Feldstein, Ph.D. Partner · Washington, DC · +1 202 408 4092 · Email ; Charles E. Lipsey · Senior Counsel · Reston, VA · +1 571 203 2755 · Email